TALL-1 is a novel member of the TNF family that is down-regulated by mitogens

Journal of Leukocyte Biology

Volumn 65, Issue 5, 1999, Pages 680-683

  Shu, Hong Bing ^a   Hu, Wen Hui ^b   Johnson, Holly ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b NONE

Author keywords

Cytokines; Leukocytes; Signal transduction

Indexed keywords

CYTOKINE; IONOMYCIN; LYMPHOTOXIN; MEMBRANE PROTEIN; MITOGENIC AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKOCYTE; LIGAND BINDING; MOLECULAR CLONING; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 0032915632     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.65.5.680     Document Type: Article

References (13)

1. Smith, C. A., Farrah, T., Goodwin, R. J. (1994) The TNF receptor superfamily of cellular and viral proteins: activation, co-stimulation, and death. Cell 76, 959-962.
2. Nataga, S. (1997) Apoptosis by death factor. Cell 88, 355-365.
3. Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tomestsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., Galibert, L. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic cell function. Nature 390, 175-179.
4. Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F., Frankel, W. N., Lee, S. Y., Choi, Y. (1997) TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272, 25190-25195.
5. Mauri, D. N., Ebner, R., Montgomery, R. I., Kochel, K. D., Cheung, T. C., Yu, G., Ruben, S., Murphy, M., Eisenberg, R. J., Cohen, G. H., Spear, P. G., Ware, C. F. (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin are ligands for herpesvirus entry mediator. Immunity 8, 21-30.
6. Chichepotiche, Y., Bourdon, P. R., Xu, H., Hsu, Y. M., Scott, H., Hession, C., Garcia, I., Browning, J. L. (1997) Tweak, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272, 32401-32410.
7. Tan, K. B., Harrop, J., Reddy, M., Young, P., Terrett, J., Emery, J., Moore, G., Truneh, A. (1997) Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene 204, 35-46.
8. Hahne, M., Kataoka, T., Schroter, M., Hofmann, K., Irmler, M., Bodmer, J., Schneider, P., Bornand, T., Holler, N., French, L. E., Sordat, B., Rimoldi, D., Tschopp, J. (1998) APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 188, 1185-1190.
9. Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H. J., Broger, C., Leotscher, H., Lesslauer, W. (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73, 431-445.
10. Eck, M. J., Sprang, S. R. (1989) The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution. J. Biol. Chem. 267, 2119-2122.
11. Svedersky, L. P., Nedwin, G. E., Goeddel, D. V., Palladino, M. A. (1985) Interferon-gamma enhances induction of lymphotoxin in recombinant interleukin 2-stimulated peripheral blood mononuclear cells. J. Immunol. 134, 1604-1608.
12. Nedwin, G. E., Svedersky, L. P., Bringman, T. S., Palladino, M. A., Goeddel, D. V. (1985) Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta. J. Immunol. 135, 2492-2498.
13. Fadok, V. A., Warner, M. L., Bratton, D. L., Henson, P. M. (1998) CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J. Immunol. 161, 6250-6257.